Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-83.76%
operating margin TTM
-191.22%
revenue TTM
165.37 Million
revenue per share TTM
5.6$
valuation ratios | |
|---|---|
| pe ratio | -0.60 |
| peg ratio | -0.04 |
| price to book ratio | 1.27 |
| price to sales ratio | 0.73 |
| enterprise value multiple | -0.23 |
| price fair value | 1.27 |
profitability ratios | |
|---|---|
| gross profit margin | 63.8% |
| operating profit margin | -191.22% |
| pretax profit margin | -171.93% |
| net profit margin | -83.76% |
| return on assets | -33.5% |
| return on equity | -227.89% |
| return on capital employed | -151.44% |
liquidity ratio | |
|---|---|
| current ratio | 1.27 |
| quick ratio | 1.06 |
| cash ratio | 0.80 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 252.28 |
| operating cycle | 317.03 |
| days of payables outstanding | 553.05 |
| cash conversion cycle | -236.02 |
| receivables turnover | 5.64 |
| payables turnover | 0.66 |
| inventory turnover | 1.45 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.52 |
| debt equity ratio | 3.31 |
| long term debt to capitalization | 0.76 |
| total debt to capitalization | 0.77 |
| interest coverage | -6.56 |
| cash flow to debt ratio | -1.06 |
cash flow ratios | |
|---|---|
| free cash flow per share | -4.70 |
| cash per share | 2.83 |
| operating cash flow per share | -3.96 |
| free cash flow operating cash flow ratio | 1.19 |
| cash flow coverage ratios | -1.06 |
| short term coverage ratios | -30.57 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time Fortress Biotech, Inc. (NASDAQ:FBIO) reported earnings?
Fortress Biotech, Inc. (FBIO) published its most recent earnings results on 14-11-2024.
What is Fortress Biotech, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Fortress Biotech, Inc. (NASDAQ:FBIO)'s trailing twelve months ROE is -227.89%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Fortress Biotech, Inc. (FBIO) currently has a ROA of -33.5%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did FBIO's net profit margin stand at?
FBIO reported a profit margin of -83.76% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is FBIO's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.27 in the most recent quarter. The quick ratio stood at 1.06, with a Debt/Eq ratio of 3.31.